About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, June 16th, 2014

The QualityStocks
Daily Stock List


Laredo Resources Corp. (LRDR)

Pumps and Dumps, PennyStocks24, 007 Stock Chat, PennyStockSpy, and Club Penny Stocks Network reported earlier on Laredo Resources Corp. (LRDR), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Laredo Resources Corp. engages in mineral exploration in the United States. The Company is presently pursuing a mineral exploration opportunity in Montana. This is known as Pony Mountain Gold, situated in the Mineral Hills District - the Pony District - in southwestern Montana. The Pony Mountain Gold property has premier infrastructure for any potential mining operations. The property sits below the Tobacco Root Mountains. Laredo Resources has its headquarters in Virginia City, Montana. The Company’s shares trade on the OTC Markets, OTCQB.

The Pony Mountain Gold property is a 4,000-acre package of properties located approximately one mile outside Pony, Montana. It consists of several previously-mined, underground, hard-rock vein systems. The Pony Mountain Gold property hosts many significant, former-producing mines. These include the Mountain Cliff, Strawberry-Keystone, Amy, and Atlantic-Pacific (A-P) mines.

Historically, the Pony Mountain Gold property has been productive. Laredo Resources believes it has potential for new productivity. Moreover, 38 additional mining claims have been added to the property. The Pony Mountain Gold property also includes approximately 100,000 tons of dump material that could undergo milling at the Golden Sunlight Mill, after appropriate assessment. The Golden Sunlight Mill is approximately 26 miles from the town of Pony.
Laredo Resources entered into a letter agreement with Magna Management Ltd. regarding the Pony Mountain Gold property. The definitive agreement for Laredo’s acquisition is in the process of being completed. The deadline for closing has been informally extended pending completion and signature of the definitive agreement.

In the event that Laredo Resources acquires Magna Management's rights to the Pony Mountain Gold property, it will assume Magna's rights and duties under a Memorandum of Understanding (MOU) between Magna and the different owners of the property. As the assignee of Magna's rights under the MOU, Laredo would be entitled to exclusive proprietary marketing rights for the property in exchange for total payments of $3,000,000 to be made in quarterly installments of $250,000 each.

Furthermore, Magna engaged Moen Excavating, LLC to take and prepare samples from dumps on the Pony Mountain Gold property, to coordinate laboratory testing of samples taken from the property, and to conduct negotiations with the Golden Sunlight-Barrick mill for the processing of material from the property. Additionally, Magna agreed to engage Moen Excavating for all surface work on the property and for the future hauling of dump material from the property to the mill. Should Laredo Resources be assigned Magna's rights to the property, its intention is to continue the engagement with Moen Excavating as Magna's assignee.

Laredo Resources Corp. (LRDR), closed Monday's trading session at $0.0004, even for the day, on 3,005,000 volume with 5 trades. The average volume for the last 60 days is 24,959,289 and the stock's 52-week low/high is $0.0002/$0.15.

MedCAREERS Group, Inc. (MCGI)

Penny Stocks On Steroids, PennyStocks24, Pumps and Dumps, and POSstocks reported earlier on MedCAREERS Group, Inc. (MCGI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTCQB, MedCAREERS Group, Inc.’s focus is to develop and build value through its wholly-owned subsidiary Nurses Lounge, Inc. Nurses Lounge is an online professional network and communication resource for nurses and stakeholder organizations. This includes nursing schools, associations, as well as employers. MedCAREER’S intention is for the Nurses Lounge to be the principal medium for information exchange for the nursing profession. MedCAREERS Group is based in Coppell, Texas.

MedCAREER’S Nurses Lounge consolidates the profession onto one user-friendly network. Nurses Lounge provides the tools and resources, which enables organizations a more effective way to communicate directly to their audience and the broader nursing profession. Nurses use the network to collaborate, exchange professional advice, and share new ideas. Mr. Tim Armes is the president and CEO of MedCAREERS Group and the Founder of Nurses Lounge.

In May, Nurses Lounge announced that three Bachelors of Science in nursing (BSN) schools each were awarded $1,000 scholarship checks. The schools are: University of Texas at Austin School of Nursing, Texas; San Francisco State University, California; and Western Carolina, North Carolina. The scholarships were offered as an incentive for expediting school participation and membership in the Nurses Lounge. Nurses Lounge is an efficient way to communicate news and information to students, alumni, as well as the broader nursing profession. The scholarship program was created as an incentive to eligible BSN schools to join and use the network while providing financial assistance to some deserving students.

Earlier in June, Nurses Lounge announced that it is working on a complete upgrade of its professional network for nurses - Nurses Lounge. Completion is scheduled for August 2014. The Network will consolidate functionality with a single sign-on for jobs and a new continuing education module launching in early fall. The site will have a responsive web design for optimal viewing across a broad spectrum of devices from mobile phones to desktop computers.

MedCAREERS Group, Inc. (MCGI), closed Monday's trading session at $0.0118, off by 5.60%, on 110,100 volume with 5 trades. The average volume for the last 60 days is 368,689 and the stock's 52-week low/high is $0.0046/$0.23.

Ener-Core, Inc. (ENCR)

Dividend Opportunities, YOLOTraderAlerts, Investopedia, The Stock Enthusiast, Todd Horwitz, TopStockAnalysts, and StreetAuthorityDaily reported this month on Ener-Core, Inc. (ENCR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Ener-Core, Inc. designs and manufactures innovative systems for producing continuous energy from a wide array of sources. This includes previously unusable ultra-low quality gas. The Ener-Core Gradual Oxidizer is the Company’s patented oxidation technology. It enables the conversion of these gases into useful heat and power with the lowest known associated emissions. Ener-Core serves several markets around the world, including oil fields, biogas, coal mines, natural gas, emissions control, and utility power generation. Ener-Core lists on the OTC Bulletin Board. The Company has its headquarters in Irvine, California.

Ener-Core offers systems with fuel flexibility and pollution control for power generation, with the Ener-Core Gradual Oxidizer matched to gas turbines. The Gradual Oxidizer can also undergo customization for integration with larger existing power generation systems to offer first-rate pollution control and achieve zero emissions.

Ener-Core has developed the 250kW Ener-Core Powerstation FP250, and its larger counterpart, the 2MW Ener-Core Powerstation KG2-3G/GO, to transform methane gas, particularly "ultra-low-Btu gas" from landfills, coal mines, oil fields and other low quality methane sources into continuous clean electricity with near-zero emissions. The specific engineering of the Powerstations are for fuel flexibility and modularity so that these low-Btu gas sources can be used as an energy resource instead of wasted through venting and/or flaring. The FP250 is a clean power generation solution using the Ener-Core Gradual Oxidation technology integrated with a 250 kW gas turbine.

In May, Ener-Core announced that it entered into a technical and commercial collaboration agreement with Raven Ridge Resources, Inc. to position and deploy Ener-Core's technology within the worldwide coal mining industry.

Mr. Alain Castro, Ener-Core’s Chief Executive Officer, stated, "Raven Ridge is one of the world's renowned experts within the area of gas-management solutions for coal mines, as well as the development of coal mine methane projects. They have focused on this niche for nearly 30 years, and have earned a strong reputation and level of trust from the entire global coal mining industry. Given their strong reputation, they are understandably cautious regarding the solutions that they associate their company with in the market, and hence we are quite proud they have elected to work with and promote the Ener-Core solution in their industry."

Earlier this month, Ener-Core announced that Mr. Jeffrey A. Horn agreed to join the Company’s Board of Directors. Mr. Horn will be completing the term of The Hon. Dr. Stephen L. Johnson, who will depart from the Board of Directors and join the newly formed Board of Advisors. Mr. Horn was formerly Managing Director of Caterpillar Power Generation Systems.

Ener-Core, Inc. (ENCR), closed Monday's trading session at $0.39, even for the day, on 21,685 volume with 8 trades. The average volume for the last 60 days is 105,954 and the stock's 52-week low/high is $0.25/$2.37.

Horizon Lines, Inc. (HRZL)

Today we are reporting on Horizon Lines, Inc. (HRZL), here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, Horizon Lines, Inc. is one of America’s foremost domestic ocean shipping companies. It is the only ocean cargo carrier serving all three non-contiguous domestic markets of Alaska, Hawaii, and Puerto Rico from the continental U.S. The Company provides reliable transportation services that take advantage of its unique combination of ocean transportation and inland distribution capabilities to deliver goods that are essential to the prosperity of the markets it serves. Horizon Lines has its corporate head office in Charlotte, North Carolina.

The Company’s Founder, Mr. Malcolm McLean, developed the metal shipping container and launched the first containerized shipping service. Sea-Land Service, the forerunner to Horizon Lines, introduced ocean-borne containerized shipping to the world in 1956. September 2005 was the Company’s initial public offering (IPO) under its new name: Horizon Lines (NYSE: HRZ). In February 2008, Horizon Lines confirmed its commitment to green business practices by joining the SmartWay Transport Partnership.

Horizon Lines owns a fleet of 13 fully Jones Act qualified vessels and operates five port terminals in Alaska, Hawaii, and Puerto Rico. It is a trusted partner for a number of the nation's top retailers, and the Company announced this past March that it was awarded the "2013 Platinum Carrier Award" by home improvement retailer Lowe's Companies, Inc.

In May, Horizon Lines reported financial results for fiscal Q1 ended March 23, 2014.  Its container volume for Q1 2014 totaled 55,223 revenue loads. This represents an increase of 7.6% from 51,321 loads for the same period in 2013.  The increase was mainly because of improved volumes in its Hawaii and Puerto Rico markets. Q1 operating revenue from continuing operations increased 3.0% to $251.9 million from $244.5 million in 2013.

The GAAP operating loss from continuing operations for Q1 totaled $8.6 million, versus an operating loss of $4.3 million the year prior. The $4.3 million decline was primarily because of higher fuel and labor costs associated with dry-docking transits and contractual cost increases that impacted marine, inland transportation, as well as terminal expenses. 

Horizon Lines, Inc. (HRZL), closed Monday's trading session at $0.365, up 1.39%, on 23,664 volume with 12 trades. The average volume for the last 60 days is 112,193 and the stock's 52-week low/high is $0.29/$1.50.

Applied Visual Sciences, Inc. (APVS)

Today we are reporting on Applied Visual Sciences, Inc. (APVS), here at the QualityStocks Daily Newsletter.

Applied Visual Sciences, Inc. is an image analysis software technology company that lists on the OTC Markets’ OTCQB. The Company designs and develops imaging informatics solutions for delivery to its target markets of aviation/homeland security and healthcare. Its technology can analyze digital images from any originating optical source. The Company previously went by the name Guardian Technologies International, Inc. It changed its name to Applied Visual Sciences, Inc. in July of 2010. The Company’s has its head office in Leesburg, Virginia.

Applied Visual Sciences has developed intelligent, next-generation imaging analytics and informatics technologies (Intelligent Imaging Informatics) for the extraction, analysis, and detection of objects-of-interest within any digital image format - still or video. Its technologies portfolio and product applications address the physiological shortcomings of human vision through providing enhanced visualization, quantification, material and tissue characterization, and automated target detection and identification capabilities.

The Company offers its two product lines through its two operating subsidiaries: Guardian Technologies International, Inc. for aviation/homeland security products and Signature Mapping Medical Sciences, Inc., for healthcare. In 2012, Applied Visual Sciences established a new entity - Instasis Imaging, Inc. - for the development, marketing, and sales of a suite of imaging analytic applications for the automated detection of breast cancer. Instasis Imaging is a wholly-owned subsidiary of Signature Mapping Medical Sciences.

The Company employs imaging technologies and analytics to create integrated information management technology products and services. These address critical problems experienced by corporations and governmental agencies in healthcare and homeland security. Each product and service can improve the quality and response time of decision-making, organizational productivity, as well as efficiency within the enterprise. Applied Visual Sciences’ product group integrates, streamlines, and distributes clinical and business information and images across the enterprise.

Applied Visual Sciences’ core technology can extract embedded knowledge from digital images. It has the capacity to analyze and detect image anomalies. The technology is not limited by kind of digital format. It can undergo deployment across divergent digital sources. This includes still images, x-ray images, video and hyper-spectral imagery. The technology has been tested in the area of threat detection for baggage scanning at airports, for bomb squad applications, and the detection of tuberculosis through analyzing digital images of stained sputum slides captured through a photo microscopy system.

The Company is presently concentrating on providing software technology solutions and services in two primary markets. These are the aforementioned aviation/homeland security with PinPoint and the aforementioned healthcare technology with Signature Mapping solutions. It markets PinPoint via Guardian Technologies. PinPoint is an "Intelligent Imaging Informatics" (3i) technology for the detection of guns, explosives, and other threat items contained in baggage in the airport environment or for building security applications. PinPoint is able to identify threat items and notify screeners of the existence of threats.

As new or enhanced solutions are developed, the Company expects to expand into other markets. These include military and defense utilizing hyper-spectral technology, and imaging diagnostics for the medical industry.

Applied Visual Sciences, Inc. (APVS), closed Monday's trading session at $0.05, even for the day, on 16,058 volume with 7 trades. The average volume for the last 60 days is 51,719 and the stock's 52-week low/high is $0.035/$0.11.


The QualityStocks
Company Corner


VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.64, even for the day. The stock’s average daily volume over the past 60 days is 5,313, and its 52-week low/high is $0.25/$0.89.

VistaGen Therapeutics Inc. today announced that the Canadian Intellectual Property Office has issued a Notice of Allowance for Canadian patent No. 2,684,022, entitled "Mesoderm and Definitive Endoderm Cell Populations." This patent, which is licensed exclusively to VistaGen by the Icahn School of Medicine at Mount Sinai in New York, will expand VistaGen's intellectual property portfolio for pluripotent stem cell culture systems that produce human cells of the endoderm lineage, including liver, lung, pancreas, parathyroid and thyroid cells.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve.  According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months.  VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits.  In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations. 

AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data.  To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Receives Notice of Allowance for Canadian Patent Expanding Stem Cell Technology Platform

VistaGen Joins HESI's Cardiac Safety Committee and Working Groups

VistaGen Receives Notice of Allowance for U.S. Patent Expanding Stem Cell Technology Platform for Drug Rescue and Regenerative Medicine

Mabwe Minerals Inc. (MBMI)

The QualityStocks Daily Newsletter would like to spotlight Mabwe Minerals Inc. (MBMI). Today, Mabwe Minerals Inc. closed trading at $0.0589, up 40.91%, on 10,284 volume with 2 trades. The stock’s average daily volume over the past 60 days is 11,539, and its 52-week low/high is $0.03/$0.70.

Mabwe Minerals Inc. (MBMI) is a U.S. based natural resources and hard asset company focused on the mining, logistics, and commercial sales of industrial minerals and metals, with a particular emphasis on barite. The company's operations are conducted through its Zimbabwe affiliate, Mabwe Mineral Zimbabwe (Private) Ltd. Transitioning into commercial production, MBMI's company fundamentals are well positioned with virtually no debt and key strategic partnerships in place.

Along with its affiliate, Mabwe Minerals Zimbabwe (Private) Ltd., an indigenous Zimbabwe company, the company owns 100% of the mineral & metal rights to Dodge Mine. The mine will be managed by the company's minority owned partner, WGB Kinsey & Company, Zimbabwe's most experienced mining & construction company representing four generations of Kinsey leadership. Management believes WGB Kinsey & Company has all the necessary equipment and management experience to efficiently perform all the mining operations at Dodge Mine.

The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc. Hydrothermal barite deposits throughout Dodge Mine represent the highest grade of new barite sources to be brought into commercial production in years. A third party oil & gas drilling sector geologist recently confirmed that the multiple barite deposits are considered "World Class" in quality and highly efficient to mine via open pit extraction following the barite veins and salvaging large percentages of barite within the halo zones via jigging systems.

With a continuing worldwide shortage of high-grade barite, Mabwe Minerals is in the right place at the right time. The company's current customer uses barite as a weighting agent in oil & gas drilling applications in the Gulf of Mexico, home to the largest concentration of active rigs in the world. Coupled with the recent massive discovery of oil & gas off the coast of neighboring Mozambique along with new drilling contracts expected in the region, MBMI is in an attractive geographical location to capture the expected demands of this emerging market. Moving from an exploration stage company into commercial barite production, Mabwe Minerals is well positioned to generate significant shareholder returns. Disclaimer

Mabwe Minerals Inc. Company Blog

Mabwe Minerals Inc. News:

Raptor Resources Holdings Issues Update on the Derbyshire Stone Quarry

Raptor Resources Holdings Acquires the Derbyshire Stone Quarry

Raptor Resources Holdings Completes Expansion of the Dodge Mine Mountain Range

Cal-Bay International, Inc. (CBYI)

The QualityStocks Daily Newsletter would like to spotlight Cal-Bay International, Inc. (CBYI). Today, Cal-Bay International, Inc. closed trading at $0.0003, even for the day, on 3,570,000 volume with 7 trades. The stock’s average daily volume over the past 60 days is 58,006,477, and its 52-week low/high is $0.0001/$0.0049.

Cal-Bay International, Inc. (CBYI) is a diversified investment holding corporation focused on constantly developing and searching for operational business acquisitions in specific sectors for development, growth and profitability. The company aims to develop multiple profit centers and residual income thus creating a stable consolidated financial environment for both the parent company and its subsidiaries.

The Pharmacy Vending division is developing a proprietary automated kiosk vending system called Pharmacy-Vend, which operates much like a bank ATM to disperse prescription medications directly to patients. Pharmacy-Vend’s advanced technology is designed to cut the rising costs of pharmacy dispensing for doctors, pharmacies and hospitals while giving patients a better, faster and secure way of providing immediate access to acute medications.

Other divisions of the company include Legal Hemp™, a wholly owned subsidiary focused on developing, producing, and distributing through the company's e-commerce storefront, products such as “THC” free edible candy products, MJ related apparel, and soon to be introduced a line of Legal Marijuana Dispensary compatible products.

Cal-Bay Financial, a wholly owned subsidiary, recently announced the development of a merchant processing network introduced as the CB Green Card. A pre-paid gift and loyalty program charge card using a similar type of platform employed by leading credit & gift card processing networks, the CB Green Card is intended for use with legal dispensaries by way of an exclusive Cal-Bay Financial Services processing terminal which will allow a seamless transaction and would further create a full report for the dispensary and tax collectors while legally transferring funds from the point of sale to the customer’s US banking institution.

The company also recently acquired the proprietary technology for the SnapGrowth™ product line, a natural enhancement solution for healthy, natural, fuller and faster growth of certain types of specialty plants. Cal-Bay Leasing™, a division dedicated to fueling the growth of Pharmacy-Vend sales and Cal-Bay Financial™ by offering in-house leasing, is also involved in pharmacy and dispensary vending equipment and point of sale processing equipment. Cal-Bay’s other subsidiaries include: Cannabis Candy Company™, Hemp Candy Company, Marijuana MEDS Pharmacy™, and MJ Expo™.

Cal-Bay’s business model is synergistic to the vast and growing opportunity for technology, products, and services that capitalize on the legalization of medical & recreational cannabis. With a well-rounded management team and go-to-market strategy in place, the company is well positioned to maximize its growth potential in various markets. Disclaimer

Cal-Bay International, Inc. Company Blog

Cal-Bay International, Inc. News:

Cal-Bay Announces Launch Of "Legal Hemp" E-Commerce Storefront

Cal-Bay Signs Distribution Agreement With California Specialty Marketing Group

Robert Thompson CEO and Walter Nicholas President of Cal-Bay International, Inc., Are Featured in a New Audio Interview at SmallCapVoice.com

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.007, even for the day, on 167,000 volume with 4 trades. The stock’s average daily volume over the past 60 days is 460,595, and its 52-week low/high is $0.004/$0.024.

Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.

Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.

In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited

Consorteum Holdings Launches New Mobile Results App for Popular Keno Game

Consorteum Holdings Enters Mobile Application Development and Business Agreement With XpertX, Inc.

NeuroMama Ltd. (NEROE)

The QualityStocks Daily Newsletter would like to spotlight NeuroMama Ltd. (NEROE). Today, NeuroMama Ltd. closed trading at $7.00, even with yesterday's close. The stock’s average daily volume over the past 60 days is 19, and its 52-week low/high is $5.00/$28.00.

NeuroMama Ltd. (NEROE) utilizes high quality neural technology to provide super-accurate search returns and power a suite of products including a web search engine, mobile app, more than 120 social networks, email service, finance center, kids zone, and more. The company is also developing the Eurasia Resort/Convention, Retail/Sport and Entertainment Complex in Las Vegas, Nevada, and is highly engaged in international multi-language streaming media distribution via TVIMama.com, Xtreme Sports production, and network/cable distribution.

NeuroZone is just one example of the numerous initiatives underway to expand NeuroMama’s brand and influence. This virtual mall will leverage all the promotional, marketing, and technologic power invested in NeuroMama’s entire stable of highly integrated, symbiotically compatible projects and strategic relationships to create the world’s first, and to date only, viable competitor to mega online retailers like Amazon and eBay. NeuroZone will provide unlimited branding opportunities for NeuroMama’s internet platform, products and services.

NeuroMama recently acquired an extensive library of entertainment assets, which includes a variety of shows, feature films, television pilots, and more. Valued at approximately $100 million dollars, this content library can be rented, liscenced and distributed an infinite number of times. The company is currently deploying an advanced, next-generation Internet Content Distribution Platform (CDP) designed to offer e-commerce merchants and entertainment programmers the most secure, fastest, and robust digital delivery system yet developed.

Other Neuromama.com platform products include NeuroMANIA.com, a child-and-parent friendly hub with 120+ social networks themed to professional and personal interests; and TVIMama.com, video-on-demand streaming and broadcasting of live television. Notably, users of the NeuroMama.com all-in-one internet platform now are earning free breathtaking luxury vacations and free magnificent international cruises with the web's premiere frequent searcher/shopper user loyalty program.

NeuroMama’s team of forward-thinking individuals have engineered an all-encompassing platform from the ground up to take maximum advantage of the last decade's advances in Web crawling, data storage and management, content comparison, analysis and sorting. With numerous opportunities to further expand in the booming Internet market, NeuroMama is well positioned to fully capitalize on its advanced neural technology. Disclaimer

NeuroMama Ltd. Company Blog

NeuroMama Ltd. News:

CES Event Showcasing Intelligent Search Engine, Online Retail Platform and Advertising Opportunities, Reception Act Performer Fall and Serious Injuries Documented

NeuroMama, Ltd. 10Q Will Be Filed In Days. Filing Is Late To Preserve $17MM Asset

NeuroMama's Global Enterprises at International CES


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters







007 Stock Chat

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251